Nykode Therapeutics’ commitment to corporate governance is based on ethics and integrity
Nykode Therapeutics works diligently to improve its guidelines and policies for corporate governance taking into account the recent trends in international and domestic requirements and recommendations.
Our activities take their outset in our core purpose “push the boundaries of human advancement by rethinking conventional drug design,” thus creating long term value for our employees, shareholders, and patients who may benefit from Nykode’s innovation.
Nykode will continue to adapt and improve our corporate governance metrics and disclosures.
Corporate Governance policy (PDF)
Instructions for the Nomination Committee (PDF)
Instructions for the Audit Committee (PDF)